Epi CanaryEpi Canary
  • Home
  • Feed
  • Synthesis
  • Assessments
  • Scopes
  • Reliability
  • Sources
Epi Canary — Epidemic IntelligenceEvidence-led epidemic intelligence. Source-attributed evidence.
Arcede logoMade by Arcede

Public note

For situational awareness and research transparency. Not medical advice.

Novel Pathogen Detectionresolved

Tunnel validation 2026-04-14T05:34Z - safe to ignore

System-generated assessment. This assessment remains under review until the stated horizon or until sufficient evidence allows evaluation.

Limited confidence

Confidence in this assessment
10%

Current evidence is sparse, early, or highly uncertain. Based on 0 linked evidence items and assessed against Dec 31, 2026.

Assessed through Dec 31, 2026·0 linked evidence items·Tracking since Apr 14, 2026

02

How this assessment will be evaluated

The criteria the system uses to determine whether this assessment is borne out by the stated horizon.

Automated

Method

Evidence Match

The condition the system checks for when evaluating this assessment.

Minimum source quality

T1Primary Institutional

Evidence must meet or exceed this credibility tier to count toward evaluation.

Required terms

2026-04-14t05validationtunnelignore

Outcome

Apr 14, 2026
Observed by horizonReliability score (Brier): 0.000

Resolved with score 0

T2·Unknown

03

Evidence quality mix

Tracking since Apr 14, 2026.

▸Integrity referencesCryptographic hashes for verification

Registration

Resolution signature

06

Scope synthesis

The current analyst narrative for this scope.

Open synthesis →

H5N1 risk trajectory steady; semen-transmission hypotheses approach Apr 28 resolution with no new USDA data; Cambodia holds at 4 YTD human cases.

07

Evidence linked to this assessment

0 linked items.

No linked evidence is available for this assessment yet.

Mirror replication is delayed on 1 of 3 tables. Showing last replicated data.

Integrity anchor

Brier 0.202

19 resolved novel pathogen detection predictions.